Crude and covariate-adjusted hazard ratios for depressive disorder among the sampled patients with gallstones in the two-year follow-up starting from the index date, stratified by sex.

<p>Crude and covariate-adjusted hazard ratios for depressive disorder among the sampled patients with gallstones in the two-year follow-up starting from the index date, stratified by sex.</p

Crude and covariate-adjusted hazard ratios for depressive disorder among the sampled patients with gallstones during the two-year follow-up starting from the index date.

<p>Crude and covariate-adjusted hazard ratios for depressive disorder among the sampled patients with gallstones during the two-year follow-up starting from the index date.</p

Five-year gallstone-free survival rates for those who underwent an appendectomy and comparison subjects.

<p>Five-year gallstone-free survival rates for those who underwent an appendectomy and comparison subjects.</p

Demographic characteristics for the sampled patients with gallstones, stratified by the presence/absence of cholecystectomy, 2001–2010 (n = 6,755).

<p>Demographic characteristics for the sampled patients with gallstones, stratified by the presence/absence of cholecystectomy, 2001–2010 (n = 6,755).</p

Sensitivity analysis.

<p>Sensitivity analysis.</p

Crude and covariate-adjusted hazard ratios (HRs) for gallstones among sampled subjects during the 5-year follow-up period by sex.

<p>Crude and covariate-adjusted hazard ratios (HRs) for gallstones among sampled subjects during the 5-year follow-up period by sex.</p

Demographic and clinical characteristics of sampled subjects (N = 9832).

<p>Demographic and clinical characteristics of sampled subjects (N = 9832).</p

Demographic characteristics of patients with chronic urticaria (CU) and controls in Taiwan (n = 19,596).

<p>Demographic characteristics of patients with chronic urticaria (CU) and controls in Taiwan (n = 19,596).</p

Poisson regression analysis, difference-in-difference method: Impact of receiving treatment for gastroesophageal reflux disease (GERD) on the annual number of acute respiratory infection episodes.

<p>Poisson regression analysis, difference-in-difference method: Impact of receiving treatment for gastroesophageal reflux disease (GERD) on the annual number of acute respiratory infection episodes.</p

Prevalence and odds ratios (ORs) for prior hyperlipidemia among sampled subjects.

<p>Prevalence and odds ratios (ORs) for prior hyperlipidemia among sampled subjects.</p